TAK-128
01-05-TL-128-006
Phase 2 small_molecule terminated
Quick answer
TAK-128 for Diabetic Neuropathies is a Phase 2 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 2 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Diabetic Neuropathies
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated